Meet us at upcoming industry events to learn how our synthetic DNA solutions can accelerate your research and therapeutic development. Our team will be on hand to discuss your needs. Book a meeting or drop by our booth to connect
Where can you meet us?
EVENTS
The Switch to Cell-Free DNA: Strategic and Regulatory Considerations for Advanced Therapies
Original broadcast: 11 DEC 2025
On-demand webinar
WATCH NOW ON DEMAND
This webinar features Amy Walker, Ph.D., CEO, joined by guest speaker Jenny Mellquist, Ph.D., for a focused discussion on the strategic, technical, and regulatory steps required to transition from plasmid DNA to synthetic, cell-free DNA for advanced therapies.
Session Focus
A practical overview of the strategic and regulatory considerations involved in updating your critical starting material to next-generation, cell-free DNA.
Key Topics
Critical regulatory and CMC requirements for material substitution
Practical considerations for implementing the change within a cGMP environment
Technical and logistical advantages of cell-free DNA over pDNA
If you're planning 2026 programs and want to explore how synthetic, cell-free DNA can accelerate timelines and improve product purity, click here to watch the webinar.
Advanced Therapies London
17-18 MARCH 2026
ExCel London, UK
We will be exhibiting at Advanced Therapies London 2026. Visit us to learn how our GMP-grade synthetic DNA solutions support the development and manufacture of advanced therapies.
We are also pleased to announce that Milena Pavlickova, Associate Director of Platform Development, will be speaking on the Viral Vector Manufacturing Track (Track 9).
Talk: Optimising AAV production with synthetic DNA templates: implications for manufacturing and safety
Tuesday, 17 March 2026 | 3:15-3:35 pm
Visit us at stand #191 to meet the team and discuss how our enzymatically produced, cell-free DNA can support your programmes from early development through to clinical and commercial manufacturing.
RNA Leaders Webinar
RNA Leaders Europe
17-19 MARCH 2026
Austria Center, Vienna
We will be exhibiting at RNA Leaders Europe, taking place 17–19 March 2026 at the Austria Center, Vienna.
Join Emily Young, Director of Scientific Applications, on the 18th March, where she will delivering a talk on the mRNA and Next-Gen RNA: Translational Therapeutics & Enabling Platforms
Talk: Synthetic DNA - The new standard in GMP-grade manufacture therapeutics.
Wednesday, 18 March 2026 | 11:30-12:00 pm
Visit us at stand #24 to meet the team and discuss how our enzymatically produced, cell-free DNA solutions can support your RNA programs from early development through to clinical and commercial manufacturing. If you would like to book a meeting, please click here.
31 MARCH 2026
Webinar, Virtual
Webinar: From Sequence to Solution: Synthetic DNA Accelerating Advanced Therapies
In this exclusive webinar, industry leaders will explore how synthetic DNA has become an essential starting material for their development pipelines.
Luigi Aurisicchio, CEO of Neomatrix Biotech, will discuss his company's groundbreaking work in personalized cancer vaccines and how synthetic DNA enables rapid translation of patient-specific tumor antigens into clinical candidates. Marianna Keaveney, CSO of HelixNano, will share insights into leveraging mRNA technology for infectious disease and cancer treatment, highlighting how synthetic DNA quality directly impacts therapeutic efficacy.
Through real-world case studies, discover how synthetic DNA is accelerating advanced therapy development, through concept to clinic faster than ever before.
Don't miss this opportunity to learn from leaders turning scientific vision into therapeutic reality.
Speakers:
Luigi Aurisicchio, CEO, Neomatrix Biotech
Marianna Keaveney, CSO, HelixNano